Aarti Pharmalabs Limited — Others, 18-01-2025: Action(s) taken or orders passed

Aarti Pharmalabs has announced a board meeting to discuss the re-opening of manufacturing activities at its Vapi plant, following the Gujarat Pollution Control Board's revocation of closure directives. The company has paid an interim environmental damage compensation of ₹3.40 lakh. Operations are set to resume without any foreseen material impacts on financials or operations. This development may bolster investor sentiment by signaling stability and swift corrective actions, presenting a positive outlook for the company's operational continuity.